Online First: Peanut Allergy New Directions in Prevention and Immunotherapy, Oncology Biosimilars Price Reductions Driving Greater Hospital Adoption

Back to news list

Source: Email Newsletter

Original: email://701...

Published: Wed, 11 Mar 2026 13:26:26 -0500 (CDT)

Article: A JAMA article discusses new directions in the prevention and immunotherapy of peanut allergy. It also addresses the topic of reducing the prices of biosimilar drugs in oncology and their impact on increased use in hospitals. The article also includes a look at patient safety, specifically the events that occur prior to the patient encounter. An overview for patients about peanut allergy is also included. The article also mentions CME articles on obesity medications, opioid prescribing for pain, management of atrial fibrillation, and vitamin D for disease prevention. It also contains poetry from the ICU environment.